Charles Sawyers
Charles L. Sawyers | |
---|---|
Born | Charles Lazelle Sawyers[1] 1959 (age 64–65) Nashville, Tennessee |
Education | Johns Hopkins University, Princeton, UCSF |
Medical career | |
Profession | Physician |
Institutions | Memorial Sloan Kettering Cancer Center Howard Hughes Medical Institute |
Sub-specialties | Oncologist |
Research | Leukemia/prostate cancer |
Awards | Lasker Clinical Award (2009) BBVA Foundation Frontiers of Knowledge Award (2014) |
Website | The Charles Sawyers Lab |
Charles L. Sawyers (born 1959) is a Howard Hughes Medical Institute (HHMI) investigator who holds the Marie-Josée and Henry R. Kravis Chair of the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center (MSK). HOPP is a program created in 2006 that comprises researchers from many disciplines to bridge clinical and laboratory discoveries.[2]
Career
Sawyers received a BA from Princeton University in 1981 and an MD from Johns Hopkins University School of Medicine in 1985,[3] followed by an internal medicine residency at the University of California, San Francisco.[4] He became a HHMI investigator in 2002 while working at UCLA's Jonsson Cancer Center.[5]
Sawyers works on molecularly targeted cancer drugs, with a focus on developing a new generation of treatment options for patients. He shared the 2009 Lasker-DeBakey Clinical Medical Research Award with Brian J. Druker and Nicholas Lydon,[6] for the development of the ABL kinase inhibitor imatinib for patients with chronic myeloid leukemia and the second-generation ABL inhibitor dasatinib to overcome imatinib resistance. He also co-discovered the antiandrogen drugs enzalutamide, approved by the FDA in 2012, and apalutamide[7] approved in 2019, both for treatment of advanced prostate cancer.[8]
Sawyers' cancer research is discussed in the second episode of Cancer: The Emperor of All Maladies.
Significant positions
Sawyers served as president of the American Society for Clinical Investigation (ASCI) in 2007[9] and of the American Association for Cancer Research (AACR) in 2012.[10] He was also appointed to the National Cancer Advisory Board by President Obama in 2012,[11] and has served on the Board of Directors of Novartis since 2013.[12] He was a founding co-editor of the Annual Review of Cancer Biology in 2017,[13] serving until 2021.[14]
Memberships
Awards
- Doris Duke Distinguished Clinical Scientist Award (2001)[15]
- David A. Karnofsky Memorial Award, American Society of Clinical Oncology (2005)[16]
- Richard and Hinda Rosenthal Foundation Award, American Association for Cancer Research (2005)[17]
- Dorothy P. Landon–AACR Prize for Translational Cancer Research (2009)[18]
- Lasker-DeBakey Clinical Medical Research Award (2009)[19]
- Breakthrough Prize in Life Sciences (2013)[20]
- Taubman Prize for Excellent in Translational Medical Science (2013)[21]
- Hope Funds for Cancer Research Award of Excellence for Clinical Development (2014)[22]
- BBVA Foundation Frontiers of Knowledge Award in Biomedicine along with Tony Hunter and Joseph Schlessinger (2014)[23]
- The Scheele Award (2017), The Swedish Academy of Pharmaceutical Science.
References
- ^ Howard Hughes Medical Institute, Annual Scientific Report, The Institute, 1990, p. 507.
- ^ "At Work: Human Oncology and Pathogenesis Program Chair Charles Sawyers | Memorial Sloan Kettering Cancer Center". www.mskcc.org. Retrieved 5 April 2017.
- ^ "Susan Schneck Weds Charles Sawyers". The New York Times. 22 October 1990. Retrieved 3 March 2017.
- ^ "UCSF Department of Medicine Alumni Profile: Dr. Charles Sawyers". medicine.ucsf.edu. Archived from the original on 8 September 2015. Retrieved 3 March 2017.
- ^ "Charles L. Sawyers, MD". HHMI.org. Retrieved 5 April 2017.
- ^ Grindlinger, Brooke; Chao, ES (1 October 2009). "Trio receives Lasker Foundation Clinical Award for breakthroughs in leukemia treatment". Journal of Clinical Investigation. 119 (10): 2863–2865. doi:10.1172/JCI41141. ISSN 0021-9738. PMC 2752112.
- ^ Tran C, Ouk S, Clegg NJ, Chen Y, Watson PA, Arora V, Wongvipat J, Smith-Jones PM, Yoo D, Kwon A, Wasielewska T, Welsbie D, Chen CD, Higano CS, Beer TM, Hung DT, Scher HI, Jung ME, Sawyers CL (2009). "Development of a second-generation antiandrogen for treatment of advanced prostate cancer". Science. 324 (5928): 787–90. Bibcode:2009Sci...324..787T. doi:10.1126/science.1168175. PMC 2981508. PMID 19359544.
- ^ Reyes, Antonio A.; Akeson, Richard (1988). "Generation of Multiple Independent Substitution Mutants by M13 in Vitro Mutagenesis Using a Single Mutagenic Oligonucleotide". DNA. 7 (8): 579–584. doi:10.1089/dna.1.1988.7.579. PMID 3180999.
- ^ "2008 American Society for Clinical Investigation Presidential Address" (PDF). the-asci.org. Retrieved 3 March 2017.
- ^ "Charles L. Sawyers, MD". aacr.org. Retrieved 4 March 2017.
- ^ "President Obama Announces More Key Administration Posts". whitehouse.gov. 6 December 2012. Retrieved 4 March 2017.
- ^ "Charles L. Sawyers, M.D. Member of the Board of Directors" (PDF). novartis.com. Retrieved 4 March 2017.
- ^ Jacks, Tyler; Sawyers, Charles (2017). "Introduction". Annual Review of Cancer Biology. 1: i. doi:10.1146/annurev-ca-01-121516-100001.
- ^ "Annual Review of Cancer Biology Editorial Committee". Annual Reviews. 2022. Retrieved 18 July 2022.
- ^ "Doris Duke Charitable Foundation Awards $10.5 Million for Medical Research". Philanthropy News Digest (PND). Retrieved 5 April 2017.
- ^ "Recipients of the David A. Karnofsky Memorial Award and Lecture - The ASCO Post". www.ascopost.com. Archived from the original on 19 September 2017. Retrieved 5 April 2017.
- ^ "Awards, Appointments, Announcements". JNCI Journal of the National Cancer Institute. 97 (11): 797. 1 June 2005. doi:10.1093/jnci/97.11.797.
- ^ "Dorothy P. Landon-AACR Prize for Translational Cancer Research". www.aacr.org. Archived from the original on 3 September 2017. Retrieved 5 April 2017.
- ^ Foundation, Lasker. "Molecularly targeted treatments for chronic myeloid leukemia | The Lasker Foundation". The Lasker Foundation. Retrieved 5 April 2017.
- ^ "Breakthrough Prize". breakthroughprize.org. Retrieved 5 April 2017.
- ^ "Taubman Prize". A. Alfred Taubman Medical Research Institute. Retrieved 16 March 2017.
- ^ "2014 Honorees". The Hope Funds for Cancer Research. 5 September 2013. Retrieved 5 April 2017.
- ^ "BBVA Foundation Frontiers of Knowledge Awards". www.fbbva.es. Archived from the original on 21 September 2015. Retrieved 5 April 2017.
External links
- Memorial Sloan Kettering Cancer Center - Biography, Lab Description
- Human Oncology and Pathogenesis Program
- Howard Hughes Medical Institute - Biography, Lab Description
- Video:Talk by Sawyers at the NIH-Lasker Clinical Research Scholars Symposium, March 31, 2011.
- Video:Speaking to Katie Couric regarding Stand Up 2 Cancer - @KatieCouric, CBS news, September 8, 2010
- Video:On outsmarting cancer - @KatieCouric, CBS news, September 8, 2010
- Quoted: New Drugs Stir Debate on Rules of Clinical Trials, New York Times, September 19, 2010
- Quoted: What can we learn from curable cancers? Newsweek, September 7, 2010
- Video: Speaking with Charlie Rose: A discussion about Cancer Treatments, October 1, 2009
- v
- t
- e
- Simon Donaldson, Maxim Kontsevich, Jacob Lurie, Terence Tao and Richard Taylor (2015)
- Ian Agol (2016)
- Jean Bourgain (2017)
- Christopher Hacon, James McKernan (2018)
- Vincent Lafforgue (2019)
- Alex Eskin (2020)
- Martin Hairer (2021)
- Takuro Mochizuki (2022)
- Daniel A. Spielman (2023)
- Simon Brendle (2024)
physics
- Nima Arkani-Hamed, Alan Guth, Alexei Kitaev, Maxim Kontsevich, Andrei Linde, Juan Maldacena, Nathan Seiberg, Ashoke Sen, Edward Witten (2012)
- Special: Stephen Hawking, Peter Jenni, Fabiola Gianotti (ATLAS), Michel Della Negra, Tejinder Virdee, Guido Tonelli, Joseph Incandela (CMS) and Lyn Evans (LHC) (2013)
- Alexander Polyakov (2013)
- Michael Green and John Henry Schwarz (2014)
- Saul Perlmutter and members of the Supernova Cosmology Project; Brian Schmidt, Adam Riess and members of the High-Z Supernova Team (2015)
- Special: Ronald Drever, Kip Thorne, Rainer Weiss and contributors to LIGO project (2016)
- Yifang Wang, Kam-Biu Luk and the Daya Bay team, Atsuto Suzuki and the KamLAND team, Kōichirō Nishikawa and the K2K / T2K team, Arthur B. McDonald and the Sudbury Neutrino Observatory team, Takaaki Kajita and Yōichirō Suzuki and the Super-Kamiokande team (2016)
- Joseph Polchinski, Andrew Strominger, Cumrun Vafa (2017)
- Charles L. Bennett, Gary Hinshaw, Norman Jarosik, Lyman Page Jr., David Spergel (2018)
- Special: Jocelyn Bell Burnell (2018)
- Charles Kane and Eugene Mele (2019)
- Special: Sergio Ferrara, Daniel Z. Freedman, Peter van Nieuwenhuizen (2019)
- The Event Horizon Telescope Collaboration (2020)
- Eric Adelberger, Jens H. Gundlach and Blayne Heckel (2021)
- Special: Steven Weinberg (2021)
- Hidetoshi Katori and Jun Ye (2022)
- Charles H. Bennett, Gilles Brassard, David Deutsch, Peter W. Shor (2023)
- John Cardy and Alexander Zamolodchikov (2024)
- Cornelia Bargmann, David Botstein, Lewis C. Cantley, Hans Clevers, Titia de Lange, Napoleone Ferrara, Eric Lander, Charles Sawyers, Robert Weinberg, Shinya Yamanaka and Bert Vogelstein (2013)
- James P. Allison, Mahlon DeLong, Michael N. Hall, Robert S. Langer, Richard P. Lifton and Alexander Varshavsky (2014)
- Alim Louis Benabid, Charles David Allis, Victor Ambros, Gary Ruvkun, Jennifer Doudna and Emmanuelle Charpentier (2015)
- Edward Boyden, Karl Deisseroth, John Hardy, Helen Hobbs and Svante Pääbo (2016)
- Stephen J. Elledge, Harry F. Noller, Roeland Nusse, Yoshinori Ohsumi, Huda Zoghbi (2017)
- Joanne Chory, Peter Walter, Kazutoshi Mori, Kim Nasmyth, Don W. Cleveland (2018)
- C. Frank Bennett and Adrian R. Krainer, Angelika Amon, Xiaowei Zhuang, Zhijian Chen (2019)
- Jeffrey M. Friedman, Franz-Ulrich Hartl, Arthur L. Horwich, David Julius, Virginia Man-Yee Lee (2020)
- David Baker, Catherine Dulac, Dennis Lo, Richard J. Youle [de] (2021)
- Jeffery W. Kelly, Katalin Karikó, Drew Weissman, Shankar Balasubramanian, David Klenerman and Pascal Mayer (2022)
- Clifford P. Brangwynne, Anthony A. Hyman, Demis Hassabis, John Jumper, Emmanuel Mignot, Masashi Yanagisawa (2023)
- Carl June, Michel Sadelain, Sabine Hadida, Paul Negulescu, Fredrick Van Goor, Thomas Gasser, Ellen Sidransky and Andrew Singleton (2024)